A long-term assessment of flurbiprofen

Area of Science:

• Rheumatology
• Clinical Pharmacology

Background:

• Arthritic conditions encompass a range of degenerative and inflammatory joint diseases.
• Effective and safe long-term treatments for arthritis are continuously sought.
• Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for symptomatic relief.

Purpose of the Study:

• To collect clinical and laboratory data on flurbiprofen in patients with various arthritic conditions.
• To evaluate the efficacy and safety of flurbiprofen in a large patient cohort.
• To assess flurbiprofen's tolerability, particularly in elderly patients.

Main Methods:

• A multi-center, open-label study design.
• Inclusion of 1220 patients with diverse arthritic conditions.
• Administration of flurbiprofen at daily dosages ranging from 75 mg to 400 mg.

Main Results:

• Flurbiprofen demonstrated effectiveness in alleviating symptoms associated with degenerative and inflammatory arthritides.
• The drug exhibited a favorable safety profile with no significant problematic side-effects reported.
• Elderly patients (65 years and older) tolerated flurbiprofen as well as younger patients.

Conclusions:

• Flurbiprofen is an effective therapeutic option for managing symptoms in various forms of arthritis.
• The drug is well-tolerated across different age groups, including the elderly, suggesting a good safety profile.
• Long-term data collection supports the utility of flurbiprofen in rheumatological practice.